Cargando…

POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY

Detalles Bibliográficos
Autores principales: AHMAD, S., Bhasin, N., Sinha, S., Sayed, S.A., Bansode, J., Swami, R., Mehta, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049664/
http://dx.doi.org/10.1016/j.ekir.2021.03.494
_version_ 1783679461180309504
author AHMAD, S.
Bhasin, N.
Sinha, S.
Sayed, S.A.
Bansode, J.
Swami, R.
Mehta, K.
author_facet AHMAD, S.
Bhasin, N.
Sinha, S.
Sayed, S.A.
Bansode, J.
Swami, R.
Mehta, K.
author_sort AHMAD, S.
collection PubMed
description
format Online
Article
Text
id pubmed-8049664
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-80496642021-04-16 POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY AHMAD, S. Bhasin, N. Sinha, S. Sayed, S.A. Bansode, J. Swami, R. Mehta, K. Kidney Int Rep Article Published by Elsevier Inc. 2021-04 2021-04-15 /pmc/articles/PMC8049664/ http://dx.doi.org/10.1016/j.ekir.2021.03.494 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
AHMAD, S.
Bhasin, N.
Sinha, S.
Sayed, S.A.
Bansode, J.
Swami, R.
Mehta, K.
POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY
title POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY
title_full POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY
title_fullStr POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY
title_full_unstemmed POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY
title_short POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY
title_sort pos-467 renal and hepatic outcomes after remdesivir therapy in covid-19 positive patients with renal dysfunction at baseline or after starting therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049664/
http://dx.doi.org/10.1016/j.ekir.2021.03.494
work_keys_str_mv AT ahmads pos467renalandhepaticoutcomesafterremdesivirtherapyincovid19positivepatientswithrenaldysfunctionatbaselineorafterstartingtherapy
AT bhasinn pos467renalandhepaticoutcomesafterremdesivirtherapyincovid19positivepatientswithrenaldysfunctionatbaselineorafterstartingtherapy
AT sinhas pos467renalandhepaticoutcomesafterremdesivirtherapyincovid19positivepatientswithrenaldysfunctionatbaselineorafterstartingtherapy
AT sayedsa pos467renalandhepaticoutcomesafterremdesivirtherapyincovid19positivepatientswithrenaldysfunctionatbaselineorafterstartingtherapy
AT bansodej pos467renalandhepaticoutcomesafterremdesivirtherapyincovid19positivepatientswithrenaldysfunctionatbaselineorafterstartingtherapy
AT swamir pos467renalandhepaticoutcomesafterremdesivirtherapyincovid19positivepatientswithrenaldysfunctionatbaselineorafterstartingtherapy
AT mehtak pos467renalandhepaticoutcomesafterremdesivirtherapyincovid19positivepatientswithrenaldysfunctionatbaselineorafterstartingtherapy